Latest News
Niagen Bioscience, Inc.
- Niagen expands at-home injection kit with new liquid format
- Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
- Niagen Bioscience Inc
- Niagen Bioscience at LD Micro event: rare-disease push takes center stage
- Quarterly financial results set for November 4, 2026 as Niagen Bioscience schedules earnings call
- Niagen Bioscience Q3FY26 Results: Earnings call set for Nov 4
- Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
- Niagen Bioscience to Present at LD Micro 20th Annual Main Event
- Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®” a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater
- Niagen Bioscience and Mass General Brigham to plan largest clinical trial of Niagen
- Niagen Bioscience signs agreement for clinical trial planning By Investing.com
- Niagen Bioscience: Down 68%, But Still Not Quite A Buy (NASDAQ:NAGE)
Headlines from the last 30 days, linking to the original publishers. See all market news →